Correlation of T3, T4 and TSH with lipid indices in obesity

V. Aruna


Background: Aim was to study the influence of Thyroid hormones on lipid indices in obese individuals. Thyroid dysfunction is a common occurence in South India. Increased accumulation of fats is a common feature of obesity and hypothyroidism.

Methods: The study was undertaken at GGH, Guntur and 150 Obese individuals with BMI of >30 were recruited. They are classified into 3 groups based on thyroid profile - Euthyroid (N=77), hypothyroid (N=45)and hyperthyroid (N=28). Their fasting venous blood samples were analysed for thyroid profile, lipid profile, FBS and creatinine. Anthropometric data like height, weight and abdominal circumference was recorded. Lipid indices, atherogenic index of plasma (AIP), Castelli’s Risk Index (CRI) 1 and 2, small dense LDL (sdLDL), Atherogenic coefficient (AC) and BMI were calculated.

Results: All the 3 groups showed female preponderance. In hypothyroid cases TSH, T3 and T4 showed significant correlation with lipid parameters (p value<0.0001) and with lipid ratios TSH and T4 significantly elevated (p value <0.00001). There was significant correlation of TSH with TC, TG and LDL between hypothyroid, hyperthyroid and euthyroid cases(p<0.0001). Spearman’s Rho correlation analysis showed negative correlation of Lipid ratios with T3, T4 and TSH in all 3 groups.(r≤1.0). Whereas multiple regression analysis of lipid ratios in all 3 groups with TSH as dependent variable demonstrated positive relation with sdLDL (p<0.01).

Conclusions: Assessment of thyroid function is mandatory in all obese individuals to predict complications especially cardiovascular disease.


Lipid indices, Obesity, Thyroid profile

Full Text:



National Family Health Survey - 5 (2019-20) phase 1, Andhra Pradesh State. Available at Accessed on 12 February 2021.

National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Available at http:// Accessed on 12 May 2021.

Palazhy S, Kamath P, Vasudevan DM. Estimation of small, dense ldl particles using equations derived from routine lipid parameters as surrogate markers. Biochem Anal Biochem. 2014;3(1):1000146.

Millán J, Pintó X, Muñoz A, Zúñiga M, Rubiés PJ, Pallardo LF, et al. Lipoprotein ratios: physiological significance and clinical usefulness in cardiovascular prevention. Vasc Health Risk Manag. 2009;5:757-65.

Fruchart JC, Davignon J, Hermans MP, Al-Rubeaan K, Amarenco P, Assmann G, et al. Residual macrovascular risk in 2013: what have we learned? Cardiovasc Diabetol. 2014;13:26.

Damiano F, Rochira A, Gnoni A, Sicurella L. Action of thyroid hormones, T3 and T2, on hepatic fatty acids: differences in metabolic effects and molecular mechanisms. Int J Mol Sci. 2017;18:744.

Chomard P, Vernhes G, Autissier N, Debry G. Serum concentrations of total T4, T3, reverse T3 and free T4, T3 in moderately obese patients. Hum Nutr Clin Nutr. 1985;39:371-8.

Reinehr T. Obesity and thyroid function. Mol Cell Endocrinol. 2010;316:165-71.

Pergola G, Ciampolillo A, Paolotti S, Trerotoli P, Giorgino R. Free triiodothyronine and thyroid stimulating hormone are directly associated with waist circumference, independent of insulin resistance, metabolic parameters and blood pressure in overweight and obese women. Clin Endocrinol. 2007;67:265-9.

Reinehr T, Isa A, Sousa G, Dieffenbach R, Andler W. Thyroid hormones and their relation to weight status. Horm Res. 2008;70:51-7.

Bhardwaj S, Bhattacharjee J, Bhatnagar MK, Tyagi S. Atherogenic index of plasma, castelli risk index and atherogenic coefficient-new parameters in assessing cardiovascular risk. Int J Pharm Bio Sci. 2013;3(3):359-64.

Manocha A, Bhargava S, Jain R, Kankra M, Singla P, Chugh P. Non-HDL as a valid surrogate marker of small dense LDL in a young indian population. Indian J Clin Biochem. 2019;34(3):263-71.

Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol without use of preparative ultracentrifuge. Clin Chem. 1972;18(6):499-504.

Harrison's Principles of Internal Medicine. 16th ed. New York: McGraw-Hill; 2005:1425-30.

Zhenjiang H, Zhaoxin M, Jingyu Z, Hong F, Jianzhang H. The correlation of blood lipid profile and its ratio, cystatin C and homocysteine of thyroid dysfunction. Am J Clin Experim Med. 2017;5(4):108-14.

Nimmanapalli HD, Kasi AD, Devapatla PK, Nuttakki V. Lipid ratios, atherogenic coefficient and atherogenic index of plasma as parameters in assessing cardiovascular risk in type 2 diabetes mellitus. Int J Res Med Sci. 2016;4:2863-9.

Liberopoulos EN, Elisaf MS. Dyslipidemia in patients with thyroid disorders. Hormones. 2002;1:218-23.

James SR, Ray L, Ravichandran K, Nanda SK. High atherogenic index of plasma in subclinical hypothyroidism: implications in assessment of cardiovascular disease risk. Indian J Endocrinol Metab. 2016;20:656-61.

Marwaha RK, Tandon N, Garg MK, Kanwar R, Sastry A, Narang A, et al. Dyslipidemia in subclinical hypothyroidism in an Indian population. Clin Biochem. 2010;44:1214-7.

Cerbone M, Capalbo D, Wasniewska M, Mattace Raso G, Alfano S, Meli R, et al. Cardiovascular risk factors in children with long standing idiopathic subclinical hypothyroidism. J Clin Endocrinol Metab. 2014;99:2697-703.

Subramanian S, Chait A. Hypertriglyceridemia secondary to obesity and diabetes. Biochim. Biophys Acta. 2012;1821:819-25.

Packard CJ. Triacylglycerol-rich lipoproteins and the generation of small, dense low-density lipoprotein. Biochem. Soc. Trans. 2003;31:1066-9.